Funding
SELECTED GRANTS
- 2023-2025: Therapeutic miRNA targeting in epilepsy: impact on excitability and beyond (GA23-05274S; investor: GACR; investigator: Prof. M. Brázdil)
- 2022-2025: Functional assessment of genetic variants in clinically “true” cases of idiopathic ventricular fibrillation: in vitro and in silico modelling to reveal the arrhythmogenic mechanism (NU22-02-00348; investor: AZV, Ministry of Health of the CR; co-investigator: Assoc. Prof. M. Bébarová)
- 2022-2025: National Institute for Neurological Research (LX22NPO5107; investor: Ministry of Education, Youth and Sports of the CR; co-investigator: Prof. I. Rektorová)
- 2022-2025: The role of neurodegeneration in pathogenesis, manifestations and prognosis of MTLE/HS – in vivo, ex vivo and in vitro perspective (NU22-04-00366; investor: AZV, Ministry of Health of the CR; co-investigator: Prof. M. Brázdil)
- 2022-2024: Macro and micro scale of high frequency epileptiform activity within human brain (GA22-28784S; investor: GACR; co-investigator: Prof. M. Brázdil)
- 2021: Neuronal excitability as a key to the pathophysiology of a number of neuropsychiatric diseases: recording of activity of in vitro models of human neural tissue using the multielectrode array technique (MUNI/11/SUP/07/2020; Internal project of Faculty of Medicine, Masaryk University; principal investigator: doc. M. Bébarová)
- 2021: In vitro modelling using patient-specific cardiomyocytes in the study of functional basis of inherited arrhythmogenic syndromes (MUNI/11/SUP/18/2020; Internal project of Faculty of Medicine, Masaryk University; principal investigator: dr. T. Bárta)
- 2016-2020: Clinical significance and electrophysiological evaluation of KCNQ1 gene mutation c.926C>T (p.T309I) as a possible long QT syndrome founder mutation (16-30571A; investor: AZV MZ ČR; co-investigator: Assoc. Prof. M. Bébarová)
- 2019: Modernization of teaching of cardiac cellular electrophysiology; MUNI/FR/1490/2018; principal investigator: Martin Macháček)
- 2019: Cardiovascular system and its regulation and dysregulation under effect of drugs; MUNI/A/1255/2018; investor: MU - specific research project; principal investigator: prof. M. Nováková)
- 2018: Cardiovascular system across disciplines – from molecular diagnostics to clinical examinations (MUNI/A/1157/2017; investor: MU - specific research project; principal investigator: M. Nováková)
- 2016: Cardiovascular system: from model through therapy to prevention; MUNI/A/1365/2015; investor: MU – specific research project; principal investigator: prof. M. Nováková)
- 2015: Cardiovascular system from cell to bedside; MUNI/A/1326/2014; investor: MU - specific research project; principal investigator: prof. M. Nováková)
- 2013 – 2015: Effect of ethanol and its principal metabolite acetaldehyde on cardiac inward rectifier potassium currents: a link to atrial fibrillation related to alcohol consumption? (NT14301-3/2013; investor: IGA, Ministry of Health of the CR; principal investigator: Assoc. Prof. M. Bébarová)
- 2003: Effects of ajmaline on membrane currents in cardiomyocytes (FRVS/492/2003; investor: University Development Fund of the Ministry of Education, Youth and Sports of the CR; principal investigator: Assoc. Prof. M. Bébarová)
- 2002 – 2004: Quantitative analysis of effect of tubular system on electrical activity of cardiac cells (GP204/02/D129; investor: Czech Science Foundation; principal investigator: Assoc. Prof. M. Pásek)